HilleVax Ownership 2024 | Who Owns HilleVax Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

6.56%

Insider Ownership

17.12%

Retail Ownership

76.32%

Institutional Holders

18.00

HilleVax Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.21.91%7.18%10,617,062835,5908.54%153,522,717Jun 30, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)8.26%0.96%4,004,231--57,901,180Jun 30, 2024
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.7.18%0.03%3,481,222419,51813.70%50,339,000Jun 30, 2024
BLACKROCK INC.4.31%0.00%2,090,604290,32716.13%30,230,134Jun 30, 2024
FRANKLIN RESOURCES INC4.10%0.01%1,987,930133,5347.20%28,745,468Jun 30, 2024
CARLYLE GROUP INC.3.79%2.51%1,838,486--26,437,429Jun 30, 2024
DEEP TRACK CAPITAL, LP3.78%0.79%1,832,652-739,808-28.76%26,500,148Jun 30, 2024
VANGUARD GROUP INC2.90%0.00%1,404,19841,5263.05%20,304,703Jun 30, 2024
CATALYS PACIFIC, LLC2.49%13.19%1,208,974-100,000-7.64%17,481,764Jun 30, 2024
JANUS HENDERSON GROUP PLC2.30%0.01%1,115,6441,115,644100.00%16,087,587Jun 30, 2024
STEPSTONE GROUP LP1.71%2.42%826,569--11,952,188Jun 30, 2024
SAMSARA BIOCAPITAL, LLC1.65%2.42%799,274--11,557,502Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.46%0.00%708,03186,21413.86%10,239,617Jun 30, 2024
BIOIMPACT CAPITAL LLC1.33%1.45%645,085645,085100.00%9,327,929Jun 30, 2024
STATE STREET CORP1.23%0.00%595,445106,71121.83%8,610,135,000Jun 30, 2024
QIMING U.S. VENTURES MANAGEMENT, LLC1.15%15.36%558,923--8,082,027Jun 30, 2024
MILLENNIUM MANAGEMENT LLC1.01%0.00%489,975-186,591-27.58%7,085,038Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.0.99%0.02%481,312481,312100.00%6,959,772Jun 30, 2024
ENSIGN PEAK ADVISORS, INC0.64%0.01%311,784194,038164.79%4,508,397Jun 30, 2024
DEUTSCHE BANK AG\0.64%0.00%311,6482,3440.76%4,506,430Jun 30, 2024

HilleVax's largest institutional shareholder is FRAZIER LIFE SCIENCES MANAGEMENT, L.P., holding 21.91% of the company's total share outstanding, currently valued at $153.52M. The top 10 institutional shareholders own together 61.04% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
QIMING U.S. VENTURES MANAGEMENT, LLC1.15%15.36%558,923--8,082,027Jun 30, 2024
CATALYS PACIFIC, LLC2.49%13.19%1,208,974-100,000-7.64%17,481,764Jun 30, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.21.91%7.18%10,617,062835,5908.54%153,522,717Jun 30, 2024
CARLYLE GROUP INC.3.79%2.51%1,838,486--26,437,429Jun 30, 2024
STEPSTONE GROUP LP1.71%2.42%826,569--11,952,188Jun 30, 2024
SAMSARA BIOCAPITAL, LLC1.65%2.42%799,274--11,557,502Jun 30, 2024
BIOIMPACT CAPITAL LLC1.33%1.45%645,085645,085100.00%9,327,929Jun 30, 2024
BRIDGER MANAGEMENT, LLC0.29%1.04%140,10031,90029.48%2,025,846Jun 30, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)8.26%0.96%4,004,231--57,901,180Jun 30, 2024
DEEP TRACK CAPITAL, LP3.78%0.79%1,832,652-739,808-28.76%26,500,148Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC0.55%0.44%265,859265,859100.00%3,844,321Jun 30, 2024
EXOME ASSET MANAGEMENT LLC0.04%0.23%18,00018,000100.00%260,280Jun 30, 2024
683 CAPITAL MANAGEMENT, LLC0.29%0.15%140,00027,00023.89%2,024,400Jun 30, 2024
VIRTUS ETF ADVISERS LLC0.01%0.04%6,1176,117100.00%88,452Jun 30, 2024
UBS OCONNOR LLC0.10%0.04%46,9701,2942.83%679,186Jun 30, 2024
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.7.18%0.03%3,481,222419,51813.70%50,339,000Jun 30, 2024
PDT PARTNERS, LLC0.05%0.03%23,07723,077100.00%333,693Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.0.99%0.02%481,312481,312100.00%6,959,772Jun 30, 2024
PRELUDE CAPITAL MANAGEMENT, LLC0.04%0.02%18,1094,10329.29%261,856Jun 30, 2024
ALGERT GLOBAL LLC0.07%0.02%35,88435,884100.00%519,000Jun 30, 2024

The largest HilleVax shareholder by % of total assets is QIMING U.S. VENTURES MANAGEMENT, LLC. The company owns 558.92K shares of HilleVax (HLVX), representing 15.36% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JANUS HENDERSON GROUP PLC2.30%0.01%1,115,6441,115,644100.00%16,087,587Jun 30, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.21.91%7.18%10,617,062835,5908.54%153,522,717Jun 30, 2024
BIOIMPACT CAPITAL LLC1.33%1.45%645,085645,085100.00%9,327,929Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.0.99%0.02%481,312481,312100.00%6,959,772Jun 30, 2024
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.7.18%0.03%3,481,222419,51813.70%50,339,000Jun 30, 2024
BLACKROCK INC.4.31%0.00%2,090,604290,32716.13%30,230,134Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC0.55%0.44%265,859265,859100.00%3,844,321Jun 30, 2024
ENSIGN PEAK ADVISORS, INC0.64%0.01%311,784194,038164.79%4,508,397Jun 30, 2024
FRANKLIN RESOURCES INC4.10%0.01%1,987,930133,5347.20%28,745,468Jun 30, 2024
STATE STREET CORP1.23%0.00%595,445106,71121.83%8,610,135,000Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC0.28%0.00%137,71389,303184.47%1,991,330Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.46%0.00%708,03186,21413.86%10,239,617Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.15%0.01%71,26171,261100.00%1,030,434Jun 30, 2024
GOLDMAN SACHS GROUP INC0.09%0.00%41,61441,614100.00%601,738Jun 30, 2024
VANGUARD GROUP INC2.90%0.00%1,404,19841,5263.05%20,304,703Jun 30, 2024
ALPS ADVISORS INC0.08%0.00%38,78738,787100.00%560,860Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.16%0.00%76,40838,786103.09%1,104,860Jun 30, 2024
D. E. SHAW & CO., INC.0.14%0.00%66,07937,920134.66%955,502Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.31%0.00%152,60236,69031.65%2,203,967Jun 30, 2024
ALGERT GLOBAL LLC0.07%0.02%35,88435,884100.00%519,000Jun 30, 2024

As of Jun 30 2024, HilleVax's largest institutional buyer is JANUS HENDERSON GROUP PLC. The company purchased 1.12M stocks of HLVX, valued at $16.09M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VR ADVISER, LLC----2,075,000-100.00%-Jun 30, 2024
DEEP TRACK CAPITAL, LP3.78%0.79%1,832,652-739,808-28.76%26,500,148Jun 30, 2024
ACUTA CAPITAL PARTNERS, LLC----250,609-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC1.01%0.00%489,975-186,591-27.58%7,085,038Jun 30, 2024
WALLEYE CAPITAL LLC----142,182-100.00%-Jun 30, 2024
CATALYS PACIFIC, LLC2.49%13.19%1,208,974-100,000-7.64%17,481,764Jun 30, 2024
BARCLAYS PLC0.02%0.00%11,820-60,450-83.64%171,000Jun 30, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC----22,512-100.00%-Jun 30, 2024
STIFEL FINANCIAL CORP----20,847-100.00%-Jun 30, 2024
UBS GROUP AG0.03%0.00%15,168-13,693-47.44%219,330Jun 30, 2024
JPMORGAN CHASE & CO0.07%-33,402-13,670-29.04%482,993Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----12,921-100.00%-Jun 30, 2024
HRT FINANCIAL LP----11,781-100.00%-Jun 30, 2024
SG AMERICAS SECURITIES, LLC----7,621-100.00%-Jun 30, 2024
NORTHERN TRUST CORP0.49%0.00%237,291-6,657-2.73%3,431,228,000Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----5,056-100.00%-Jun 30, 2024
MORGAN STANLEY0.12%0.00%58,172-4,861-7.71%841,167Jun 30, 2024
ENTRYPOINT CAPITAL, LLC----4,802-100.00%-Jun 30, 2024
STATE OF WISCONSIN INVESTMENT BOARD0.05%0.00%23,401-3,927-14.37%338,378Jun 30, 2024
TOROSO INVESTMENTS, LLC0.02%0.00%10,874-1,591-12.76%157,238Jun 30, 2024

As of Jun 30 2024, HilleVax's biggest institutional seller is VR ADVISER, LLC. The company sold -2.08M shares of HLVX, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JANUS HENDERSON GROUP PLC2.30%0.01%1,115,6441,115,644100.00%16,087,587Jun 30, 2024
BIOIMPACT CAPITAL LLC1.33%1.45%645,085645,085100.00%9,327,929Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.0.99%0.02%481,312481,312100.00%6,959,772Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC0.55%0.44%265,859265,859100.00%3,844,321Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.15%0.01%71,26171,261100.00%1,030,434Jun 30, 2024
ALPS ADVISORS INC0.08%0.00%38,78738,787100.00%560,860Jun 30, 2024
ALGERT GLOBAL LLC0.07%0.02%35,88435,884100.00%519,000Jun 30, 2024
PDT PARTNERS, LLC0.05%0.03%23,07723,077100.00%333,693Jun 30, 2024
EXOME ASSET MANAGEMENT LLC0.04%0.23%18,00018,000100.00%260,280Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.04%0.00%16,95616,956100.00%245,184Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC0.03%0.00%15,68815,688100.00%226,849Jun 30, 2024
MAVEN SECURITIES LTD0.03%0.01%15,00015,000100.00%216,900Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.03%0.00%13,01613,016100.00%188,211Jun 30, 2024
TREXQUANT INVESTMENT LP0.02%0.00%10,40910,409100.00%150,514Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/0.02%-10,06310,063100.00%146,000Jun 30, 2024
VIRTUS ETF ADVISERS LLC0.01%0.04%6,1176,117100.00%88,452Jun 30, 2024
QUEST PARTNERS LLC0.00%0.00%832832100.00%12,031Jun 30, 2024
QUARRY LP0.00%0.00%6161100.00%882Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-2828100.00%405Jun 30, 2024
PNC FINANCIAL SERVICES GROUP, INC.--1515100.00%217Jun 30, 2024
ROTHSCHILD INVESTMENT LLC--1010100.00%145Jun 30, 2024

HilleVax's largest new institutional shareholder by number of shares is JANUS HENDERSON GROUP PLC, purchased 1.12M shares, valued at $16.09M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VR ADVISER, LLC----2,075,000-100.00%-Jun 30, 2024
ACUTA CAPITAL PARTNERS, LLC----250,609-100.00%-Jun 30, 2024
WALLEYE CAPITAL LLC----142,182-100.00%-Jun 30, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC----22,512-100.00%-Jun 30, 2024
STIFEL FINANCIAL CORP----20,847-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----12,921-100.00%-Jun 30, 2024
HRT FINANCIAL LP----11,781-100.00%-Jun 30, 2024
SG AMERICAS SECURITIES, LLC----7,621-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----5,056-100.00%-Jun 30, 2024
ENTRYPOINT CAPITAL, LLC----4,802-100.00%-Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY----1,561-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----4-100.00%-Jun 30, 2024

HilleVax's largest sold out institutional shareholder by shares sold is VR ADVISER, LLC, sold -2.08M shares, valued at -, as of undefined.

HilleVax Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Zacks Trust0.20%18,13018,130-Feb 29, 2024
T. Rowe Price Small-Cap Stock Fund, Inc.0.17%633,086265,50172.23%Mar 31, 2024
T. Rowe Price Small-Cap Value Fund, Inc.0.12%913,389567,127163.79%Mar 31, 2024
ALGER FUNDS0.09%87,043--Jan 31, 2024
FRANKLIN STRATEGIC SERIES0.07%619,65644,0007.64%Jan 31, 2024
TEKLA LIFE SCIENCES INVESTORS0.06%27,000--Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.03%16,335--Mar 31, 2024
T. Rowe Price Equity Funds, Inc.0.03%276,209124,35581.89%Mar 31, 2024
FIDELITY COMMONWEALTH TRUST0.01%24,3508,40452.70%Feb 29, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%3,995--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%39,829--Mar 31, 2024
VANGUARD INDEX FUNDS0.00%1,095,982-571,165-34.26%Mar 31, 2024
ALPS ETF Trust0.00%27,700--Feb 29, 2024
T. Rowe Price Spectrum Funds II, Inc.0.00%28,15811,70671.15%Feb 29, 2024
SCHWAB CAPITAL TRUST0.00%74,54918,39632.76%Jan 31, 2024
ETF Managers Trust0.00%12,2817506.50%Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%255,80590,49254.74%Feb 29, 2024
Calvert Variable Products, Inc.0.00%2,714--Mar 31, 2024
FIDELITY COVINGTON TRUST0.00%10,1173,43451.38%Jan 31, 2024
Amplify ETF Trust0.00%12,46512,465-Mar 31, 2024
T. Rowe Price Equity Series, Inc.0.00%69628569.34%Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%12,134-6,691-35.54%Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%8,998-1,337-12.94%Mar 31, 2024
VANGUARD WORLD FUND0.00%65,97216,66933.81%Feb 29, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,184--Mar 31, 2024
SCHWAB STRATEGIC TRUST0.00%137,97647,37552.29%Feb 29, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%11,912--Mar 31, 2024
Federated Hermes Global Allocation Fund0.00%1,781181.02%Feb 29, 2024
Global X Funds0.00%8,001--Jan 31, 2024
AMERICAN CENTURY ETF TRUST0.00%17,15412,183245.08%Feb 29, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%9,0007008.43%Mar 31, 2024
NORTHERN FUNDS0.00%19,079-182-0.94%Mar 28, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%1,45555962.39%Mar 31, 2024
TIAA-CREF LIFE FUNDS0.00%256--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%1,636855.48%Mar 31, 2024
iSHARES TRUST0.00%975,480-4,939-0.50%Mar 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%116,42732,69039.04%Feb 29, 2024
EQ ADVISORS TRUST0.00%61,8602,3353.92%Mar 31, 2024
RYDEX SERIES FUNDS0.00%194--Dec 31, 2023
Dimensional ETF Trust0.00%18,31317,3401782.12%Jan 31, 2024
VALIC Co I0.00%10,0611,88223.01%Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%4,055--Mar 31, 2024
Direxion Shares ETF Trust0.00%4,441--Jan 31, 2024
PENN SERIES FUNDS INC0.00%800--Mar 28, 2024
Invesco Exchange-Traded Self-Indexed Fund Trust0.00%5,365--Feb 29, 2024
RYDEX DYNAMIC FUNDS0.00%96--Dec 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC0.00%22,70718,722469.81%Jan 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%2,57947922.81%Jan 31, 2024
ProFunds0.00%204-17-7.69%Mar 31, 2024
PROSHARES TRUST0.00%3,841-1,912-33.23%Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%31,3182,4308.41%Mar 31, 2024
TIAA-CREF FUNDS0.00%34,3145,48219.01%Jan 31, 2024
RYDEX VARIABLE TRUST0.00%13--Dec 31, 2023
Brighthouse Funds Trust II0.00%9,157--Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%2,31080253.18%Jan 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%10,524--Mar 31, 2024
MASSMUTUAL SELECT FUNDS0.00%9,886--Dec 31, 2023
MORGAN STANLEY PATHWAY FUNDS0.00%892--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%2,97055522.98%Jan 31, 2024
Brinker Capital Destinations Trust0.00%384--Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%10,231-356-3.36%Mar 31, 2024
FIDELITY SALEM STREET TRUST0.00%17,974-117-0.65%Mar 31, 2024
ETF Series Solutions0.00%60--Jan 31, 2024
PACIFIC SELECT FUND0.00%10,021-180-1.76%Mar 31, 2024
Invesco Exchange-Traded Fund Trust II0.00%821--Jan 31, 2024
Bridge Builder Trust0.00%9,545--Mar 31, 2024
BlackRock Variable Series Funds, Inc.0.00%3,264--Mar 31, 2024
Advisors' Inner Circle Fund III0.00%612779.41%Jan 31, 2024
BLACKROCK FUNDS0.00%3,718--Jan 31, 2024
PRINCIPAL FUNDS, INC.0.00%3,29039713.72%Jan 31, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%4,2801,80072.58%Feb 29, 2024

HilleVax's largest mutual fund holder by % of total assets is "Zacks Trust", owning 18.13K shares, compromising 0.20% of its total assets.

HilleVax Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2418-77.22%
31 Mar, 247916.18%
31 Dec, 2368-
30 Sep, 236825.93%
30 Jun, 2354-11.48%
31 Mar, 23618.93%
31 Dec, 22569.80%
30 Sep, 2251-7.27%
30 Jun, 2255-

As of 30 Jun 24, 18 institutions are holding HilleVax's shares, representing a decrease of -77.22% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 243,179,402-91.45%
31 Mar, 2437,178,2794.62%
31 Dec, 2335,536,4884.11%
30 Sep, 2334,134,47134.36%
30 Jun, 2325,405,469-3.80%
31 Mar, 2326,409,1270.07%
31 Dec, 2226,391,80812.75%
30 Sep, 2223,407,3070.79%
30 Jun, 2223,224,940-

HilleVax (HLVX) has 3.18M shares outstanding as of 30 Jun 24, down -91.45% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 246.56%0.11%
31 Mar, 2478.18%0.94%
31 Dec, 2391.03%1.13%
30 Sep, 2389.94%1.99%
30 Jun, 2367.29%1.38%
31 Mar, 2369.95%0.74%
31 Dec, 2297.22%2.47%
30 Sep, 2262.71%0.82%
30 Jun, 2287.60%-

As of 30 Jun 24, HilleVax is held by 6.56% institutional shareholders, representing a 0.11% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2414-65.00%
31 Mar, 2440-11.11%
31 Dec, 2345-6.25%
30 Sep, 234841.18%
30 Jun, 23349.68%
31 Mar, 2331-20.51%
31 Dec, 223950.00%
30 Sep, 2226-52.73%
30 Jun, 2255-

14 institutional shareholders have increased their position in HLVX stock as of 30 Jun 24 compared to 40 in the previous quarter (a -65.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 241-95.65%
31 Mar, 242391.67%
31 Dec, 231233.33%
30 Sep, 239-
30 Jun, 239-47.06%
31 Mar, 2317240.00%
31 Dec, 225-66.67%
30 Sep, 2215-
30 Jun, 22--

1 institutional shareholders have reduced their position in HLVX stock as of 30 Jun 24 compared to 23 in the previous quarter (a -95.65% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2418-77.22%3,179,402-91.45%6.56%0.11%14-65.00%1-95.65%
31 Mar, 247916.18%37,178,2794.62%78.18%0.94%40-11.11%2391.67%
31 Dec, 2368-35,536,4884.11%91.03%1.13%45-6.25%1233.33%
30 Sep, 236825.93%34,134,47134.36%89.94%1.99%4841.18%9-
30 Jun, 2354-11.48%25,405,469-3.80%67.29%1.38%349.68%9-47.06%
31 Mar, 23618.93%26,409,1270.07%69.95%0.74%31-20.51%17240.00%
31 Dec, 22569.80%26,391,80812.75%97.22%2.47%3950.00%5-66.67%
30 Sep, 2251-7.27%23,407,3070.79%62.71%0.82%26-52.73%15-
30 Jun, 2255-23,224,940-87.60%-55---

HilleVax Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 22, 2024Kohli Adityadirector-S-SaleSell6,000$15.45$92.69K776,878
May 22, 2024Kohli Adityadirector-S-SaleSell6,000$14.21$85.23K770,878
May 22, 2024Kohli Adityadirector-S-SaleSell6,000$14.73$88.37K764,878
May 03, 2024Kohli Adityadirector-S-SaleSell175$14.03$2.46K789,601
May 03, 2024Kohli Adityadirector-S-SaleSell6,000$14.01$84.08K783,601
May 03, 2024Kohli Adityadirector-S-SaleSell723$14.15$10.23K782,878
Apr 08, 2024Frazier Life Sciences X, L.P.10 percent owner-P-PurchaseBuy8,850$14.50$128.32K8,544,187
Apr 05, 2024Kohli Adityadirector-S-SaleSell6,000$14.93$89.58K801,776
Apr 05, 2024Kohli Adityadirector-S-SaleSell6,000$14.71$88.25K795,776
Apr 05, 2024Kohli Adityadirector-S-SaleSell6,000$14.44$86.64K789,776
Apr 01, 2024McLoughlin Seanofficer Chief Operating OfficerP-PurchaseBuy1,250$16.98$21.23K1,250
Mar 20, 2024Kohli Adityadirector-S-SaleSell6,000$17.66$105.94K819,776
Mar 20, 2024Kohli Adityadirector-S-SaleSell6,000$17.42$104.49K813,776
Mar 20, 2024Kohli Adityadirector-S-SaleSell6,000$164.22K$985.33M807,776
Mar 08, 2024Kohli Adityadirector-S-SaleSell6,000$18.95$113.70K837,776
Mar 08, 2024Kohli Adityadirector-S-SaleSell6,000$18.37$110.21K831,776
Mar 08, 2024Kohli Adityadirector-S-SaleSell6,000$18.66$111.96K825,776
Feb 22, 2024Kohli Adityadirector-S-SaleSell6,000$14.88$89.27K855,776
Feb 22, 2024Kohli Adityadirector-S-SaleSell6,000$14.92$89.49K849,776

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 08, 2024Frazier Life Sciences X, L.P.10 percent owner-P-PurchaseBuy8,850$14.50$128.32K8,544,187
Apr 01, 2024McLoughlin Seanofficer Chief Operating OfficerP-PurchaseBuy1,250$16.98$21.23K1,250

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 22, 2024Kohli Adityadirector-S-SaleSell6,000$15.45$92.69K776,878
May 22, 2024Kohli Adityadirector-S-SaleSell6,000$14.21$85.23K770,878
May 22, 2024Kohli Adityadirector-S-SaleSell6,000$14.73$88.37K764,878
May 03, 2024Kohli Adityadirector-S-SaleSell175$14.03$2.46K789,601
May 03, 2024Kohli Adityadirector-S-SaleSell6,000$14.01$84.08K783,601
May 03, 2024Kohli Adityadirector-S-SaleSell723$14.15$10.23K782,878
Apr 05, 2024Kohli Adityadirector-S-SaleSell6,000$14.93$89.58K801,776
Apr 05, 2024Kohli Adityadirector-S-SaleSell6,000$14.71$88.25K795,776
Apr 05, 2024Kohli Adityadirector-S-SaleSell6,000$14.44$86.64K789,776
Mar 20, 2024Kohli Adityadirector-S-SaleSell6,000$17.66$105.94K819,776
Mar 20, 2024Kohli Adityadirector-S-SaleSell6,000$17.42$104.49K813,776
Mar 20, 2024Kohli Adityadirector-S-SaleSell6,000$164.22K$985.33M807,776
Mar 08, 2024Kohli Adityadirector-S-SaleSell6,000$18.95$113.70K837,776
Mar 08, 2024Kohli Adityadirector-S-SaleSell6,000$18.37$110.21K831,776
Mar 08, 2024Kohli Adityadirector-S-SaleSell6,000$18.66$111.96K825,776
Feb 22, 2024Kohli Adityadirector-S-SaleSell6,000$14.88$89.27K855,776
Feb 22, 2024Kohli Adityadirector-S-SaleSell6,000$14.92$89.49K849,776

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 31, 2024Frazier Life Sciences X, L.P.-Buy----
May 22, 2024Kohli Adityadirector-S-SaleSell6,000$15.45$92.69K776,878
May 22, 2024Kohli Adityadirector-S-SaleSell6,000$14.21$85.23K770,878
May 22, 2024Kohli Adityadirector-S-SaleSell6,000$14.73$88.37K764,878
May 03, 2024Kohli Adityadirector-S-SaleSell175$14.03$2.46K789,601
May 03, 2024Kohli Adityadirector-S-SaleSell6,000$14.01$84.08K783,601
May 03, 2024Kohli Adityadirector-S-SaleSell723$14.15$10.23K782,878
Apr 08, 2024Frazier Life Sciences X, L.P.10 percent owner-P-PurchaseBuy8,850$14.50$128.32K8,544,187
Apr 05, 2024Kohli Adityadirector-S-SaleSell6,000$14.93$89.58K801,776
Apr 05, 2024Kohli Adityadirector-S-SaleSell6,000$14.71$88.25K795,776
Apr 05, 2024Kohli Adityadirector-S-SaleSell6,000$14.44$86.64K789,776
Apr 01, 2024McLoughlin Seanofficer Chief Operating OfficerP-PurchaseBuy1,250$16.98$21.23K1,250
Mar 20, 2024Kohli Adityadirector-S-SaleSell6,000$17.66$105.94K819,776
Mar 20, 2024Kohli Adityadirector-S-SaleSell6,000$17.42$104.49K813,776
Mar 20, 2024Kohli Adityadirector-S-SaleSell6,000$164.22K$985.33M807,776
Mar 08, 2024Kohli Adityadirector-S-SaleSell6,000$18.95$113.70K837,776
Mar 08, 2024Kohli Adityadirector-S-SaleSell6,000$18.37$110.21K831,776
Mar 08, 2024Kohli Adityadirector-S-SaleSell6,000$18.66$111.96K825,776
Feb 22, 2024Kohli Adityadirector-S-SaleSell6,000$14.88$89.27K855,776
Feb 22, 2024Kohli Adityadirector-S-SaleSell6,000$14.92$89.49K849,776

The last insider sell of HilleVax's stock was made by Kohli Aditya on May 22 2024, selling 6,000 shares at $15.45 per share (valued at $92.69K). The last insider buy of HLVX was made by Frazier Life Sciences X, L.P. on Apr 08 2024, buying 8,850 shares at $14.50 per share (worth $128.32K).

HilleVax Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20241911.11%
Q1 2024101471.43%
Q4 2023-5-
Q2 202371700.00%
Q1 202382400.00%
Q4 202211100.00%
Q3 20229--
Q2 202231127.27%

1 total buy trades, and 9 total sell trades (buy/sell ratio of 0.11%) were made by HilleVax's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20241911.11%
Q1 20241147.14%
Q4 2023-5-
Q2 2023---
Q1 2023---
Q4 2022---
Q3 2022---
Q2 20222--

As of Q2 2024, Insider owners conducted 1 open market buy trades and 9 open market sell trades of HilleVax's stocks.

HilleVax Peer Ownership


TickerCompany
VIGLVigil Neuroscience, Inc.
PMVPPMV Pharmaceuticals, Inc.
CGEMCullinan Oncology, Inc.
CNTACentessa Pharmaceuticals plc
MLYSMineralys Therapeutics, Inc.
EWTXEdgewise Therapeutics, Inc.
IPSCCentury Therapeutics, Inc.
STROSutro Biopharma, Inc.
CSBRChampions Oncology, Inc.
TRDAEntrada Therapeutics, Inc.
CCCCC4 Therapeutics, Inc.
GLUEMonte Rosa Therapeutics, Inc.
MNOVMediciNova, Inc.
PHVSPharvaris N.V.
PEPGPepGen Inc.
MOLNMolecular Partners AG
PRDSPardes Biosciences, Inc.
OPTOpthea Limited
STTKShattuck Labs, Inc.
ELYMEliem Therapeutics, Inc.

HLVX Ownership FAQ


HilleVax is owned by institutional shareholders (6.56%), insiders (17.12%), and public (76.32%). The largest institutional shareholder of HilleVax is FRAZIER LIFE SCIENCES MANAGEMENT, L.P. (21.91% of total shares) and the top mutual fund owner is Zacks Trust (0.20% of total shares).

HilleVax's major institutional shareholders are FRAZIER LIFE SCIENCES MANAGEMENT, L.P., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), T. ROWE PRICE INVESTMENT MANAGEMENT, INC., BLACKROCK INC., and FRANKLIN RESOURCES INC. The top five shareholders own together 45.77% of the company's share outstanding.

As of Jun 2024, there are 18 institutional shareholders of HilleVax.

FRAZIER LIFE SCIENCES MANAGEMENT, L.P owns 10.62M shares of HilleVax, representing 21.91% of the company's total shares outstanding, valued at $153.52M (as of Jun 2024).

As of Jun 2024, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) holds 4M shares of HilleVax (HLVX), compromising 8.26% of the company, valued at $57.9M.

T. ROWE PRICE INVESTMENT MANAGEMENT, INC is the third largest holder of HilleVax. The company owns 3.48M of the company's shares outstanding (worth $50.34M).